Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis
Sebastian Klapa, Specialist in Internal Medicine and Rheumatology at University of Lübeck, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Hot off the press
ANCA-associated vasculitis (AAV) and the risk of mortality and cardiovascular morbidity.
In our recent paper, which has been accepted by Frontiers-Immunology, we focused on real-world data for mortality and a wide range of cardiovascular diseases in an enlarged cohort of over 20,000 AAV patients over a period of up to 20 years.
For the first time, we were able to compare over 5,000 MPA patients with GPA patients.
Key findings:
- Increased risk of death in AAV patients
- Elevated risk of all screened cardiovascular comorbidities, especially major adverse cardiac events (MACE)
- MPA patients presented an increased risk of MACE and peripheral arterial disease
Be aware of your AAV patients, even those in stable remission.
In addition to symptom-related diagnostics, we may need to regularly screen for cardiovascular diseases.
Many thanks to all the co-authors for their great contributions!”
Title: ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study
Authors: Sebastian Klapa, Katja Bieber, Artem Vorobyev, Marlene Ludwig, Gordon Vollert, Sabrina Arnold, Henning Olbrich, Henry Nording, Antje Müller, Khalaf Kridin, Jan Henrik Schirmer, Katja von Allwörden, Anja Staehle, Ralf Ludwig, Peter Lamprecht

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development
-
Oct 20, 2026, 03:13Sumyea Kabir: Pre-Analytical Quality in Phlebotomy – Preventing In Vitro Hemolysis
-
Oct 20, 2026, 02:37M. Sekip Altunkan: Can Anticoagulation Be Safely Stopped After AF Ablation?
-
Oct 20, 2026, 02:26Ahmed Ammar: Managing VT Recurrence Post-Ablation
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation